Intas to buy Teva's generic biz in UK, Ireland for ₹5k cr
Ahmedabad-based Intas Pharmaceuticals has agreed to buy Israeli drugmaker Teva's generic drug business in the UK and Ireland, for an enterprise value of approximately £600 million (₹5,083 crore) in an all-cash deal. The acquisition will expand Intas’ UK manufacturing presence and will more than double its pan-European operations. The deal will be finalised in the next three months.